JFG
RGNX icon

Jefferies Financial Group’s Regenxbio RGNX Stock Holding History

Jefferies Financial Group’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-95,400
Closed -$799K – 1989
2026
Q1 		$799K Buy
+95,400
New +$1M 0.01% 1010
2023
Q2 		– Sell
-67,311
Closed -$1.27M – 1948
2023
Q1 		$1.27M Buy
+67,311
New +$1.49M 0.01% 810

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Jefferies Financial Group's RGNX Position: Q2 2026 in Review

Jefferies Financial Group sold out of Regenxbio (RGNX) in Q2 2026, closing a stake of 95,400 shares — an estimated $799K sold.

Jefferies Financial Group first reported a position in RGNX in Q1 2023 and held it in 2 quarters. The position peaked at $1.27M in Q1 2023. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Jefferies Financial Group reported no remaining Regenxbio position as of Q2 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 95,400 Regenxbio shares in Q2 2026, an estimated $799K.
  • Jefferies Financial Group first reported a position in Regenxbio in Q1 2023 and held it in 2 quarters.
  • Jefferies Financial Group's Regenxbio position peaked at $1.27M in Q1 2023.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.